Abstract
Three pyrrolyl heteroaryl sulfones (ethyl 1-[(1H-benzimidazol-2(3H)one-5-yl)sulfonyl]-1H-pyrrole-2-carboxyla te, ethyl 1-[(1H-benzimidazol-5(6)-yl)sulfonyl]-1H-pyrrole-2-carboxylate and ethyl 1-[(1H-benzotriazol-5(6)-yl)sulfonyl]-1H-pyrrole-2-carboxylate) were designed as novel HIV-1 reverse transcriptase non-nucleoside inhibitors using structure-based computational methods. Although these compounds were inactive in the cell-based assay, they inhibited the target enzyme with micromolar potency (IC50s = 2 microM, 3 microM and 9 microM, respectively).
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-HIV Agents / chemical synthesis*
-
Anti-HIV Agents / chemistry
-
Anti-HIV Agents / pharmacology
-
Benzimidazoles / chemical synthesis
-
Benzimidazoles / pharmacology
-
Cell Division / drug effects
-
Cell Survival / drug effects
-
Computer-Aided Design
-
Drug Design*
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology
-
HIV-1 / drug effects
-
Inhibitory Concentration 50
-
Proline / analogs & derivatives*
-
Proline / chemical synthesis
-
Proline / pharmacology
-
RNA-Directed DNA Polymerase / drug effects*
-
Sulfones / chemical synthesis
-
Sulfones / pharmacology*
Substances
-
Anti-HIV Agents
-
Benzimidazoles
-
Enzyme Inhibitors
-
Sulfones
-
2-pyrrolecarboxylic acid
-
Proline
-
RNA-Directed DNA Polymerase